```html

Keratoconjunctival Dryness (Dry Eye Disease)

What is Keratoconjunctival Dryness?

Keratoconjunctival dryness, commonly known as dry eye disease (DED), is a condition in which the ocular surface—specifically the cornea and conjunctiva—does not receive enough moisture or the tear film is of poor quality. Tears are essential for keeping the eye clear, providing nutrients, and protecting against infection. When the tear film becomes unstable, patients experience irritation, visual discomfort, and, if left untreated, damage to the corneal epithelium.

Dry eye can be aqueous‑deficient (insufficient tear production), evaporative (excess tear evaporation), or a combination of both. The condition is chronic and often fluctuates with environmental factors, systemic health, and medication use.

Common Causes

Many systemic, ocular, and environmental factors can disrupt tear production or increase tear evaporation. Below are the most frequently encountered causes:

• Meibomian Gland Dysfunction (MGD) – blockage or poor quality of the oily layer that prevents rapid evaporation.
• Age‑related decline – tear production naturally decreases after age 40, especially in women after menopause.
• Autoimmune diseases – Sjögren’s syndrome, rheumatoid arthritis, and lupus attack the lacrimal glands.
• Medications – antihistamines, antidepressants, beta‑blockers, isotretinoin, and diuretics can reduce tear output.
• Contact lens wear – lens material and poor fit can disrupt the tear film.
• Environmental exposure – dry climates, wind, air‑conditioned or heated rooms, and prolonged screen time.
• Ocular surgery – LASIK, cataract extraction, or trabeculectomy may damage corneal nerves that stimulate tearing.
• Blepharitis – inflammation of the eyelid margin interferes with lipid secretion.
• Allergic conjunctivitis – chronic rubbing and inflammation worsen tear instability.
• Systemic dehydration – inadequate fluid intake can diminish tear volume.

Associated Symptoms

Patients with keratoconjunctival dryness often report a constellation of symptoms that may vary throughout the day:

• Burning, stinging, or gritty sensation (“feels like sand in the eye”)
• Foreign‑body sensation or the feeling of something being “in” the eye
• Redness of the conjunctiva
• Excessive tearing (reflex tearing) after prolonged irritation
• Blurred vision that improves with blinking
• Light sensitivity (photophobia)
• Difficulty wearing contact lenses
• Eye fatigue, especially after reading or using digital devices

When to See a Doctor

Most mild cases can be managed with over‑the‑counter lubricants, but certain warning signs warrant prompt ophthalmologic evaluation:

• Persistent discomfort lasting more than a few weeks despite self‑care
• Sudden worsening of symptoms, especially after eye surgery or trauma
• Recurrent eye infections or ulcers
• Significant visual changes that do not resolve after blinking
• Unexplained redness combined with pain or discharge
• History of autoimmune disease or systemic medication that can affect tear production

Early professional assessment helps prevent corneal damage and preserves quality of life.

Diagnosis

Eye care professionals use a combination of symptom questionnaires, clinical tests, and imaging to confirm dry eye and identify its type.

1. Patient History & Symptom Scores

• Ocular Surface Disease Index (OSDI) – a validated questionnaire that quantifies symptom severity.
• Detailed review of medications, systemic illnesses, and environmental exposures.

2. Visual‑Acuity and Slit‑Lamp Examination

• Assess for fluorescein staining patterns that highlight epithelial defects.
• Examine eyelid margins for blepharitis or meibomian gland plugging.

3. Tear‑Film Tests

• Schirmer Test – filter paper placed under the lower lid measures aqueous tear production (≤5 mm in 5 min suggests aqueous deficiency).
• Tear Breakup Time (TBUT) – fluorescein dye observes how quickly the tear film destabilizes; < 10 seconds is abnormal.
• Non‑invasive TBUT (NITBUT) – uses a keratometer or specialized camera, avoiding dye irritation.
• Osmolarity testing – elevated tear osmolarity (>308 mOsm/L) is a hallmark of dry eye.
• Lipid layer assessment – interferometry evaluates meibomian gland secretions.

4. Imaging

• Meibography – infrared imaging visualizes meibomian gland morphology.
• Corneal topography – detects subtle surface irregularities caused by chronic dryness.

Treatment Options

Treatment is individualized based on the underlying mechanism (aqueous‑deficient vs. evaporative) and disease severity.

1. Lifestyle & Environmental Modifications

• Increase ambient humidity (humidifiers) and avoid direct airflow from fans or AC.
• Take regular “20‑20‑20” breaks when using screens: every 20 minutes look at something 20 feet away for 20 seconds.
• Wear wrap‑around sunglasses outdoors to reduce wind‑induced evaporation.
• Stay hydrated; aim for at least 8 glasses of water daily.

2. Over‑the‑Counter (OTC) Lubricants

• Preservative‑free artificial tears (e.g., Refresh Optive, Systane Ultra) used 4–6 times daily.
• Gel or ointment formulations at night for prolonged coating.

3. Prescription Medications

• Cyclyclate (Restasis) – topical cyclosporine A improves tear production by reducing ocular surface inflammation.
• Lifitegrast (Xiidra) – an LFA‑1 antagonist that decreases inflammatory cytokines on the ocular surface.
• Topical corticosteroids (short‑course) for acute flare‑ups under close supervision.
• Oral omega‑3 fatty acid supplements (EPA/DHA) 1–2 g/day to enhance meibomian gland lipid quality.

4. Meibomian Gland Therapy

• Warm compresses (5–10 minutes) followed by gentle lid massage to melt obstructed secretions.
• In‑office LipiFlow® thermal pulsation or intense pulsed light (IPL) therapy for refractory MGD.

5. Punctal Occlusion

• Silicone or collagen plugs placed in the tear drainage puncta to retain tears on the ocular surface.
• Temporary (collagen) plugs are useful for trial; permanent silicone plugs are considered for chronic cases.

6. Autologous Serum Eye Drops

• Prepared from the patient’s own blood; contain growth factors and vitamins that promote epithelial healing.
• Reserved for severe, refractory dry eye when standard therapy fails.

7. Surgical Options (rare)

• Minor salivary gland transplantation or tarsorrhaphy for extreme ocular surface exposure.

Prevention Tips

While some risk factors (age, genetics) cannot be changed, many practical steps can reduce the likelihood of developing or worsening keratoconjunctival dryness:

• Maintain a balanced diet rich in omega‑3 fatty acids (fatty fish, flaxseed, chia).
• Limit caffeine and alcohol, which can contribute to dehydration.
• Use preservative‑free artificial tears before long‑duration screen work or travel.
• Adopt proper eyelid hygiene: warm compresses + lid scrub (e.g., diluted baby shampoo) twice daily if you have blepharitis.
• Wear protective eyewear in windy or dusty environments.
• Discuss medication side‑effects with your physician; alternatives may be available.
• Schedule regular eye examinations, especially if you have an autoimmune condition or use contact lenses.

Emergency Warning Signs

Key Take‑aways

Keratoconjunctival dryness is a common, often multifactorial condition that can dramatically affect comfort and visual function. Early recognition, targeted treatment, and lifestyle adjustments can control symptoms and protect the ocular surface. Always consult an eye‑care professional if symptoms persist, worsen, or are accompanied by red‑flag signs.

References:

• Mayo Clinic. “Dry Eye.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/dry-eye
• Cleveland Clinic. “Dry Eye Syndrome.” 2022. https://my.clevelandclinic.org/health/diseases/17610-dry-eye-syndrome
• National Eye Institute (NEI). “Dry Eye.” 2021. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/dry-eye
• American Academy of Ophthalmology. “Dry Eye Disease Preferred Practice Pattern.” 2024.
• European Society of Ophthalmology. “Management of Meibomian Gland Dysfunction.” Ophthalmology Review, 2023.

```